Ultrahigh-speed swept-source OCT angiography in exudative AMD

Ophthalmic Surgery Lasers and Imaging Retina

Volumn 45, Issue 6, 2014, Pages 496-505

  Moult, Eric ^a,b   Choi, Woojhon ^a   Waheed, Nadia K ^c   Adhi, Mehreen ^c   Lee, Byung Kun ^a   Lu, Chen D ^a   Jayaraman, Vijaysekhar ^d   Potsaid, Benjamin ^a,e   Rosenfeld, Philip J ^f   Duker, Jay S ^c   Fujimoto, James G ^a  

^a USA   (United States)

^b HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

^c TUFTS MEDICAL CENTER   (United States)

^d Praevium Research Inc   (United States)

^e Advanced Imaging Group   (United States)

^f UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN INHIBITOR;

A SCAN; ADULT; AGE RELATED MACULAR DEGENERATION; AGED; ARTICLE; B SCAN; BRUCH MEMBRANE; CHOROID CAPILLARY LAYER; CHOROID DISEASE; CHOROID VASCULARIZATION; CLINICAL ARTICLE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EXUDATE; EXUDATIVE AGE RELATED MACULAR DEGENERATION; EYE MOVEMENT; FEMALE; FOLLOW UP; GEOGRAPHIC ATROPHY; HUMAN; INTERFEROMETER; INTRAOCULAR PRESSURE; MALE; OBSERVATIONAL STUDY; OPTICAL COHERENCE TOMOGRAPHY; OPTICAL COHERENCE TOMOGRAPHY DEVICE; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; RETINA BLOOD VESSEL; RETINA DETACHMENT; RETINA HEMORRHAGE; SENSITIVITY ANALYSIS; SIGNAL NOISE RATIO; SUBRETINAL FLUID; SUBRETINAL NEOVASCULARIZATION; ULTRAHIGH SPEED SWEPT SOURCE OPTICAL COHERENCE TOMOGRAPHIC ANGIOGRAPHY; ANGIOGRAPHY; CHOROID; CHOROIDAL NEOVASCULARIZATION; CILIARY ARTERY; MIDDLE AGED; PATHOLOGY; RADIOGRAPHY; VASCULARIZATION; VERY ELDERLY; WET MACULAR DEGENERATION; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANGIOGRAPHY; CHOROID; CHOROIDAL NEOVASCULARIZATION; CILIARY ARTERIES; CROSS-SECTIONAL STUDIES; EXUDATES AND TRANSUDATES; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETINAL VESSELS; TOMOGRAPHY, OPTICAL COHERENCE; WET MACULAR DEGENERATION; YOUNG ADULT;

EID: 84918509731     PISSN: 23258160     EISSN: 23258179     Source Type: Journal    
DOI: 10.3928/23258160-20141118-03     Document Type: Article

References (41)

1. Rosenfeld PJ, Moshfeghi AA, Puliafto CA. Optical coherence tomography fndings after an intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmic Surg Lasers Imaging Retina. 2005;36(4):331-335.
2. Kaiser PK, Blodi BA, Shapiro H, et al. Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration. Ophthalmology. 2007;114(10):1868-1875.
3. Fung AE, Lalwani GA, Rosenfeld PJ, et al. An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibi-zumab (lucentis) for neovascular age-related macular degeneration. Am J Ophthalmol. 2007;143(4):566-583.
4. Lalwani GA, Rosenfeld PJ, Fung AE, et al. A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macu-lar degeneration: year 2 of the PrONTO Study. Am J Ophthalmol. 2009;148(1):43-58.
5. Hong Y-J, Miura M, Makita S, et al. Noninvasive investigation of deep vascular pathologies of exudative macular diseases by high-penetration optical coherence angiography. Invest Ophthalmol Vis Sci. 2013;54(5):3621-3631.
6. Jia Y, Bailey S T, Wilson DJ, et al. Quantitative optical coherence tomography angiography of choroidal neovascularization in age-related macular degeneration. Ophthalmology. 2014;121(7):1435-1444.
7. Albert DM, Miller JW, Azar DT, Blodi BA. Albert & Jakobiec's Principles & Practice of Ophthalmolog y. 3rd ed. Philadelphia, PA: Saunders Elsevier; 2008.
8. Ryan S, Schachat A, Wilkinson C, et al. Retina. 5th ed. Philadelphia, PA: Saunders Elsevier; 2013.
9. Bressler NM, Doan QV, Varma R, et al. Estimated cases of legal blindness and visual impairment avoided using ranibizumab for choroidal neovascularization: non-Hispanic white population in the United States with age-related macular degeneration. Arch Ophthalmol. 2011;129(6):709-717.
10. Gragoudas ES, Adamis A P, Cunningham ET, et al. Pegaptanib for neovascular age-related macular degeneration. New Engl J Med. 2004;351(27):2805-2816.
11. Brown DM, Kaiser PK, Michels M, et al. Ranibizumab versus verte-porfn for neovascular age-related macular degeneration. New Engl J Med. 2006;355(14):1432-1444.
12. Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neo-vascular age-related macular degeneration. New Engl J Med. 2006;355(14):1419-1431.
13. Schmidt-Erfurth UM, Pruente C. Management of neovascular age-related macular degeneration. Prog Retin Eye Res. 2007;26(4):437-451.
14. Bressler NM. Antiangiogenic approaches to age-related macular degeneration today. Ophthalmology. 2009;116(10):S15-S23.
15. Martin D F, Maguire MG, Fine SL, et al. Ranibizumab and bevaci-zumab for treatment of neovascular age-related macular degeneration: two-year results. Ophthalmology. 2012;119(7):1388-1398.
16. Bischoff P, Flower R. Ten years experience with choroidal angiography using indocyanine green dye: a new routine examination or an epilogue? Doc Ophthalmol. 1985;60(3):235-291.
17. Flower R. Extraction of choriocapillaris hemodynamic data from ICG fuorescence angiograms. Invest Ophthalmol Vis Sci. 1993;34(9):2720-2729.
18. Zhu L, Zheng Y, von Kerczek CH, et al. Feasibility of Extracting Velocity Distribution in Choriocapillaris in Human Eyes from ICG Dye Angiograms. J Biomech Eng. 2005;128(2):203-209.
19. Bhutto I, Lutty G. Understanding age-related macular degeneration (AMD): Relationships between the photoreceptor/retinal pigment epithelium/Bruch's membrane/choriocapillaris complex. Mol Aspects Med. 2012;33(4):295-317.
20. McLeod DS, Taomoto M, Otsuji T, et al. Quantifying changes in RPE and choroidal vasculature in eyes with age-related macular degeneration. Invest Ophthalmol Vis Sci. 2002;43(6):1986-1993.
21. McLeod DS, Grebe R, Bhutto I, et al. Relationship between RPE and choriocapillaris in age-related macular degeneration. Invest Ophth Vis Sci. 2009;50(10):4982-4991.
22. Fein JG, Branchini LA, Manjunath V, et al. Analysis of short-term change in subfoveal choroidal thickness in eyes with age-related mac-ular degeneration using optical coherence tomography. Ophthalmic Surg Lasers Imaging Retina. 2014;45(1):32-37.
23. Kim S, Oh J, Kwon S, et al. Comparison of Choroidal Thickness among Patients with Healthy Eyes, Early Age-Related Maculopathy, Neovascular Age-Related Macular Degeneration, Central Serous Cho-rioretinopathy, and Polypoidal Choroidal Vasculopathy. Retina-J Ret Vit Dis. 2011;31(9):1904-1911.
24. Makita S, Hong Y, Yamanari M, et al. Optical coherence angiography. Opt Express. 2006;14(17):7821-7840.
25. Fingler J, Schwartz D, Yang CH, et al. Mobility and transverse fow visualization using phase variance contrast with spectral domain optical coherence tomography. Opt Express. 2007;15(20):12636-12653.
26. Tao YK, Davis AM, Izatt JA. Single-pass volumetric bidirectional blood fow imaging spectral domain optical coherence tomography using a modifed Hilbert transform. Opt Express. 2008;16(16):12350-12361.
27. An L, Wang RKK. In vivo volumetric imaging of vascular perfusion within human retina and choroids with optical micro-angiography. Opt Express. 2008;16(15):11438-11452.
28. Mariampillai A, Standish BA, Moriyama EH, et al. Speckle variance detection of microvasculature using swept-source optical coherence tomography. Opt Lett. 2008;33(13):1530-1532.
29. Vakoc BJ, Lanning RM, Tyrrell JA, et al. Three-dimensional microscopy of the tumor microenvironment in vivo using optical frequency domain imaging. Nat Med. 2009;15(10):1219-1223.
30. Yu L F, Chen Z P. Doppler variance imaging for three-dimensional retina and choroid angiography. J Biomed Opt. 2010;15(1):1-4.
31. Jonathan E, Enfeld J, Leahy MJ. Correlation mapping: rapid method for retrieving microcirculation morphology from optical coherence tomography intensity images. P Soc Photo-Opt Ins. 2011;7898(1):1-5.
32. Blatter C, Klein T, Grajciar B, et al. Ultrahigh-speed non-invasive widefeld angiography. J Biomed Opt. 2012;17(7):1-4.
33. Jia YL, Tan O, Tokayer J, et al. Split-spectrum amplitude-decorre-lation angiography with optical coherence tomography. Opt Express. 2012;20(4):4710-4725.
34. Choi W, Mohler KJ, Potsaid B, et al. Choriocapillaris and choroidal microvasculature imaging with ultrahigh speed OCT angiography. PLOS ONE. 2013;8(12):e81499.
35. Schwartz DM, Fingler J, Kim DY, et al. Phase-variance optical coherence tomography: a technique for noninvasive angiography. Ophthalmology. 2014;121(1):180-187.
36. Grulkowski I, Liu JJ, Potsaid B, et al. Retinal, anterior segment and full eye imaging using ultrahigh speed swept source OCT with vertical-cavity surface emitting lasers. Biomed Opt Express. 2012;3(11):2733-2751.
37. Choi W, Potsaid B, Jayaraman V, et al. Phase-sensitive swept-source optical coherence tomography imaging of the human retina with a vertical cavity surface-emitting laser light source. Opt Lett. 2013;38(3):338-340.
38. Guizar-Sicairos M, Thurman ST, Fienup JR. Effcient subpixel image registration algorithms. Opt Lett. 2008;33(2):156-158.
39. Sunness JS, Gonzalez-Baron J, Bressler NM, et al. The development of choroidal neovascularization in eyes with the geographic atrophy form of age-related macular degeneration. Ophthalmology. 1999;106(5):910-919.
40. Ramrattan RS, van der Schaft TL, Mooy CM, et al. Morphometric analysis of Bruch's membrane, the choriocapillaris, and the choroid in aging. Invest Ophth Vis Sci. 1994;35(6):2857-2864.
41. Flower RW, von Kerczek C, Zhu L, et al. Theoretical investigation of the role of choriocapillaris blood fow in treatment of subfoveal choroidal neovascularization associated with age-related macular degeneration. Am J Ophthalmol. 2001;132(1):85-93.